PH01000558G0410's details annotation
1.Annotation
ICBR annotation: NBS-LRR disease resistance protein, putative
Blast result AT3G14460 : 4.40E-69
Blast annotation: LRR and NB-ARC domains-containing disease resistance protein
2.Location
Scaffold: PH01000558
Strand: +
| Region | Start | End |
| gene | 251153 | 265162 |
| mRNA | 251153 | 265162 |
| exon | 251153 | 252266 |
| exon | 253375 | 253465 |
| exon | 255257 | 259968 |
| exon | 260235 | 260283 |
| exon | 261031 | 261122 |
| exon | 261189 | 261321 |
| exon | 261586 | 261608 |
| exon | 261789 | 261874 |
| exon | 262766 | 262866 |
| exon | 263817 | 263888 |
| exon | 264076 | 264109 |
| exon | 264761 | 265162 |
| CDS | 252154 | 252266 |
| CDS | 253375 | 253465 |
| CDS | 255257 | 259968 |
| CDS | 260235 | 260283 |
| CDS | 261031 | 261122 |
| CDS | 261189 | 261321 |
| CDS | 261586 | 261608 |
| CDS | 261789 | 261874 |
| CDS | 262766 | 262866 |
| CDS | 263817 | 263888 |
| CDS | 264076 | 264109 |
| CDS | 264761 | 264810 |
3.Network
| Co-expression Network Category | Global Network | Conditional Network | |
| Co-expression Positive |
Top300 PCC genelist MR network genelist |
Top300 PCC genelist MR network genelist |
|
| Co-expression Negative |
Top300 PCC genelist MR network genelist |
Top300 PCC genelist MR network genelist |
|
| Predict protein-portein interaction | null | ||
| miRNA-targets relationship | null | ||
4.Functional module
| Method | Module ID | Function Annotation |
| coexpression network | null | null |
5.Cis-elements
Details in 3kb promoter region
6.Expression profilings
7.Gene family
| Category | Family |
| null | null |
8.Protein domain
| Pfam Accession | Pfam Annotation | Alignment Start | Alignment Start |
| PF00931.21 | NB-ARC | 410 | 670 |
| PF14764.5 | SPG48 | 1638 | 1731 |
9.KEGG Pathway
| Pathway | KEGG Ortholog | Pathway ID | KO |
| null | null | null | null |
10.Gene Ontology
| GO Accession | GO Annotation |
| GO:0006952 | defense response |
| GO:0043531 | ADP binding |
Maintained by Xuelian Ma - Zhen Su's Lab - China Agricultural University
© 2017 All Rights Reserved.
© 2017 All Rights Reserved.